China Pharma Begins First Work On Producing H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
China's Hualan Biological Engineering says it has begun producing a solution aimed at creating a vaccine against the H1N1 flu virus. The company said it began work just hours after receiving seed viruses from the World Health Organization. Hualan is the only company certified in China to produce a pandemic vaccine, but 10 makers of seasonal-flu vaccines also are expected to receive the seed viruses. The head of SFDA's biology production office said the first batch of vaccines is expected to be produced as early as late July. The WHO has yet to decide whether the H1N1 flu virus is seasonal or pandemic. (Click here for more